Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Protein Kinase Inhibitors"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Chen%2C+Jianhua%22&type=Person&filter%5B%5D=topic_facet%3A%22Protein+Kinase+Inhibitors%22
/vufind/Search/Results?lookfor=%22Chen%2C+Jianhua%22&type=Person&filter%5B%5D=topic_facet%3A%22Protein+Kinase+Inhibitors%22
Search /vufind/Search2/Results?lookfor=%22Chen%2C+Jianhua%22&type=Person&filter%5B%5D=topic_facet%3A%22Protein+Kinase+Inhibitors%22
PubPharm (13)
1
Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib-refractory ALK-positive NSCLC from a phase II study
enthalten in:
Cancer communications (London, England)
| 2024
von
Zheng, J.
|
Wang, T.
|
Yang, Y.
| +41
Wird geladen...
2
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions
enthalten in:
The New England journal of medicine
| 2023
von
Zhou, C.
|
Tang, K.
|
Cho, B.
| +126
CommentIn: Cancer Discov. 2023 Dec 12;13(12):OF9. - PMID 37878779
Wird geladen...
3
Efficacy and safety of iruplinalkib (WX-0593) in ALK-positive crizotinib-resistant advanced non-small cell lung cancer patients : a single-arm, multicenter phase II study (INTELLECT)
enthalten in:
BMC medicine
| 2023
von
Shi, Y.
|
Chen, J.
|
Zhang, H.
| +30
Wird geladen...
4
Efficacy and Safety of SH-1028 in Patients With EGFR T790M-Positive NSCLC : A Multicenter, Single-Arm, Open-Label, Phase 2 Trial
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2022
von
Xiong, A.
|
Ren, S.
|
Liu, H.
| +34
Wird geladen...
5
AENEAS : A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon-Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2022
von
Lu, S.
|
Dong, X.
|
Jian, H.
| +56
CommentIn: J Clin Oncol. 2022 Sep 20;40(27):3103-3105. - PMID 35679530
Wird geladen...
6
Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC : Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2022
von
Lu, S.
|
Wang, Q.
|
Zhang, G.
| +39
CommentIn: Nat Rev Clin Oncol. 2022 Jan;19(1):6. - PMID 34845385
Wird geladen...
7
Safety and activity of WX-0593 (Iruplinalkib) in patients with ALK- or ROS1-rearranged advanced non-small cell lung cancer : a phase 1 dose-escalation and dose-expansion trial
enthalten in:
Signal transduction and targeted therapy
| 2022
von
Shi, Y.
|
Fang, J.
|
Hao, X.
| +26
Wird geladen...
8
Safety but Limited Efficacy of Ensartinib in ROS1-Positive NSCLC : A Single-Arm, Multicenter Phase 2 Study
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2021
von
Ai, X.
|
Wang, Q.
|
Cheng, Y.
| +21
Wird geladen...
9
Decoding the Evolutionary Response to Ensartinib in Patients With ALK-Positive NSCLC by Dynamic Circulating Tumor DNA Sequencing
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2021
von
Yang, Y.
|
Huang, J.
|
Wang, T.
| +41
Wird geladen...
10
Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC : A Multicenter, Open-label, Phase 1 Trial
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2020
von
Yang, J.
|
Camidge, D.
|
Yang, C.
| +26
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Protein Kinase Inhibitors
Medienart
13
Aufsätze
13
E-Artikel
13
E-Ressourcen
Zeitschriftentitel
5
Journal of thoracic oncology : official publica...
1
BMC medicine
1
Cancer communications (London, England)
1
Journal of clinical oncology : official journal...
1
Lung cancer (Amsterdam, Netherlands)
1
Signal transduction and targeted therapy
1
The Journal of pathology
1
The Lancet. Respiratory medicine
1
The New England journal of medicine
Alle anzeigen ...
weniger ...
Thema
13
Journal Article
Protein Kinase Inhibitors
12
EC 2.7.10.1
11
Research Support, Non-U.S. Gov't
8
Multicenter Study
6
Clinical Trial, Phase II
5
Anaplastic Lymphoma Kinase
5
EGFR protein, human
5
ErbB Receptors
4
Piperazines
4
Pyridazines
4
SMA5ZS5B22
4
ensartinib
3
53AH36668S
3
Acrylamides
3
Aniline Compounds
3
Antineoplastic Agents
3
Crizotinib
3
EGFR T790M mutation
3
Protein-Tyrosine Kinases
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
12
2020-
1
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
13
Englisch
Haven't found what you're looking for?
Wird geladen...